Zak Williams joins SF startup Headlamp Health to advise on Lumos AI, an effort to spot early mental‑health signs.

STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio ...

Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...

Fosun Adgenvax (Chengdu) joins an IPO wave that raised more than US$1.5 billion last year for biotech companies The board of ...

Across the life sciences sector, funding is being tied more closely to operational goals. Risk and legal teams are setting ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Inc. has recently rebranded as Deinium Therapeutics Inc., is changing its Nasdaq ticker to DFTX, and outlined a late-stage ...

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best High Yield Stocks to Buy. On January 7, UBS upgraded Bristol-Myers Squibb Company (NYSE:BMY) to a Buy from Neutral. The firm ...

If you are wondering whether Charles River Laboratories International is reasonably priced at around US$219.70, you are not ...

Karolinska Development today announced that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a ...

STOCKHOLM, SWEDEN - January 21, 2026. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has signed a binding term sheet with Exeltis, a global Women ...